Patient Pathfinder: Clinical Trials
Clinical Trials for Melanoma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 454 active Melanoma trials
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Study Type: Interventional Phase 1
Rural Adult and Youth Sun Protection Study
Study Type: Interventional
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Study Type: Interventional Phase 2
Study of IT STX-001 in Patients With Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Study Type: Interventional Phase 1
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
Study Type: Observational
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
Study Type: Interventional Phase 3
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Study Type: Interventional Phase 1
Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1
Study Type: Interventional Phase 1
There are 454 active Melanoma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now